Skip to main content
. 2007 Jan 31;9(1):R16. doi: 10.1186/bcr1649

Figure 3.

Figure 3

Distant disease-free survival of immunohistochemically CK5/14-negative and CK5/14-positive tumors in the whole data set. The basal cytokeratin-positive tumors show significantly shorter survival during the first years of the follow-up, but this difference is lost with time.